Combined therapy with the estrogen receptor ERα and IFNα-2b suppresses HBV replication by inducing GBP1 expression
Pegylated interferon α-2b (peg IFNα-2b) is a first-line clinical drug for the treatment of chronic hepatitis B (CHB). It can effectively reduce HBsAg levels, improve clinical cure rates, and lower the incidence of HBV-associated hepatocellular carcinom…